Diabetes Technology Archive

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Children

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Children

Recommendations for utilizing trend arrow data in a mobile continuous glucose monitoring system were recently issued for pediatric patients with type 1 diabetes.

Effect of Prior Glucose Monitoring on Glycemic Outcomes With a Hybrid Closed-Loop System

Effect of Prior Glucose Monitoring on Glycemic Outcomes With a Hybrid Closed-Loop System

Patients with prior experience using a continuous glucose monitoring system may benefit from the MiniMed 670G HCL system therapy.

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

A remotely connected diabetes management system increased patent satisfaction and improved glycemic control in patients with insulin-treated diabetes.

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

Interpreting trend arrow data from continuous glucose monitoring may provide additional data to improve glycemic control in adults with diabetes mellitus.

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

Adapting open-loop settings that are used by the artificial pancreas algorithm is easily understandable and transparent to both patients and physicians.

Efficacy of CGM in Preterm Infants of Mothers With Diabetes

Efficacy of CGM in Preterm Infants of Mothers With Diabetes

Real-time continuous glucose monitoring systems are comparable to traditional blood glucose monitoring methods in preterm infants.

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

With this statement, researchers hope to improve safety and efficacy outcomes, advance technology, and improve patient quality of life and health outcomes.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Machines were used to examine the glycemic impact of various meals to determine a glucose forecast.

NIH Announces Major Artificial Pancreas Clinical Trials

NIH Announces Major Artificial Pancreas Clinical Trials

The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.

Continuous Glucose Monitoring Improves HbA1c in T1D

Continuous Glucose Monitoring Improves HbA1c in T1D

Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

The FDA's expanded indication for the Dexcom G5 Continuous Glucose Monitoring System allows for replacement of fingerstick glucose testing.

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients With Diabetes

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients With Diabetes

The system allows patients and their caregivers to access glucose measurements through their pump or through a mobile app.

Contour Next One Glucose Monitoring System Approved by FDA

Contour Next One Glucose Monitoring System Approved by FDA

The Contour®Next One Blood Glucose Management System will be available in early 2017.

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

An implantable continuous glucose monitor appears to be a safe and effective alternative to a transcutaneous monitor in diabetes.

The 'Artificial Pancreas' Has Arrived

The 'Artificial Pancreas' Has Arrived

FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

Approval was based on a clinical trial that included 123 people with type 1 diabetes who used the MiniMed 670G hybrid closed-loop system for 3 months, after a 2-week period of no use.

Artificial Pancreas Moving Steadily Toward Commercial Approval

Artificial Pancreas Moving Steadily Toward Commercial Approval

The FDA is coordinating with investigators, manufacturers, clinicians, and others to bring automated insulin delivery devices to market.

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

The system was feasible, safe, and effective for managing hyperglycemia in this patient population.

Artificial Pancreas Protocol Considered Safe, Feasible for Young Children With Type 1 Diabetes

Artificial Pancreas Protocol Considered Safe, Feasible for Young Children With Type 1 Diabetes

Artificial pancreas was linked to 3-fold reduction of time-in-hypoglycemia for 5- to 9-year-olds.

Digital Assistant to Artificial Pancreas Improved Glucose Control in Type 1 Diabetes

Digital Assistant to Artificial Pancreas Improved Glucose Control in Type 1 Diabetes

Overnight-only and 24/7 closed-loop control reduced hypoglycemia and increased time in range.

Sweat-Sensing Patch Can Monitor Glucose Levels, Deliver Diabetes Medication

Sweat-Sensing Patch Can Monitor Glucose Levels, Deliver Diabetes Medication

Experimental technology senses blood glucose and delivers medicine with microneedles.

Insulin Pump Therapy Had Durable Effect in Type 2 Diabetes

Insulin Pump Therapy Had Durable Effect in Type 2 Diabetes

Insulin pump therapy is more effective than multiple daily injections for glycemic control in patients with type 2 diabetes.

Long-Term Insulin Pump Therapy Decreases Mortality in Type 1 Diabetes

Long-Term Insulin Pump Therapy Decreases Mortality in Type 1 Diabetes

Long-term use of insulin pump reduces fatal coronary heart disease, cardiovascular disease and all-cause mortality.

Imperium Instant Patch Insulin Pump Launched

Imperium Instant Patch Insulin Pump Launched

Unilife Corporation announced the launch of the Imperium, the first instant patch pump for insulin with Bluetooth connectivity for patients with diabetes.

Blood Glucose Meter Accuracy Called Into Question

Blood Glucose Meter Accuracy Called Into Question

The paper raises questions regarding safety for measuring blood glucose, and when blood glucose meters are used in trials.

'Smart' Insulin Patch Shows Promise for Diabetes

'Smart' Insulin Patch Shows Promise for Diabetes

The novel technology could be a game-changer for patients with diabetes.

A Call for Improved Surveillance of Insulin Pump Therapy

A Call for Improved Surveillance of Insulin Pump Therapy

Experts are now calling for a more standardized and transparent approach to identifying and reporting adverse events with insulin pump therapy.

Insulin Pump Safety Addressed in Joint Statement

Insulin Pump Safety Addressed in Joint Statement

A statement from the EASD and the ADA indicates that modern insulin pump technologies could be further improved by adopting a more rigorous, standardized and transparent approach to safety.

FDA Clears t:flex Insulin Pump for Marketing

FDA Clears t:flex Insulin Pump for Marketing

The FDA has cleared the t:flex Insulin Pump, which has the largest capacity available in the U.S., for marketing.

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

The FDA has approved the Animas Vibe insulin pump and continuous glucose monitoring system for patients with diabetes.

Artificial Pancreas Effective in Unsupervised, At-Home Setting

Artificial Pancreas Effective in Unsupervised, At-Home Setting

Type 1 diabetes patients experienced improved glucose control and less hypoglycemia with use of an artificial pancreas vs. sensor-augmented pump therapy.

Roche Launches First Glucose Meter With Insulin Calculator

Roche Launches First Glucose Meter With Insulin Calculator

Roche announced the launch of Accu-Chek Aviva Expert system, the first blood glucose meter with a built-in insulin calculator.

The Artificial Pancreas: Revolutionizing Type 1 Diabetes Care

The Artificial Pancreas: Revolutionizing Type 1 Diabetes Care

Patients with type 1 diabetes may improve glucose control while reducing the frequency of hypoglycemic episodes with the arrival of the artificial pancreas.

Sign Up for Free e-Newsletters

CME Focus